VeriMomkaempferol hamilelikte güvenli mi?
No harmonised CLP (H360/H361) or CIR/SCCS cosmetic safety opinion was found for kaempferol, but multiple peer‑reviewed animal and in vitro studies show reproductive‑endocrine activity (e.g., progestogenic effects in ovariectomized rats and modulation of embryonic development in vitro), supporting a ‘suspected’ reproductive concern; systemic exposure from topical cosmetic use is likely low but measurable. (See rat in vivo progestogenic study and embryo/bovine in vitro studies; ECHA registration shows dossiers but not harmonised classification).
Hamilelikte kaempferol yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- kaempferol hamilelikte güvenli mi?
- No harmonised CLP (H360/H361) or CIR/SCCS cosmetic safety opinion was found for kaempferol, but multiple peer‑reviewed animal and in vitro studies show reproductive‑endocrine activity (e.g., progestogenic effects in ovariectomized rats and modulation of embryonic development in vitro), supporting a ‘suspected’ reproductive concern; systemic exposure from topical cosmetic use is likely low but measurable. (See rat in vivo progestogenic study and embryo/bovine in vitro studies; ECHA registration shows dossiers but not harmonised classification).
- kaempferol emzirirken güvenli mi?
- No specific human lactation data were found. Animal and mechanistic data showing endocrine activity and systemic bioactivity (progestogenic/estrogenic modulation) justify a suspected concern for breastfeeding (possible maternal systemic effects and theoretical transfer), while dermal cosmetic exposure is expected to give low but measurable systemic absorption. (See cited in vivo and mechanistic studies and ECHA registration).
- kaempferol bebek cildi için güvenli mi?
- Infant‑specific reproductive evidence was not found (so hazard and mechanism are not increased beyond the adult assessment), but because kaempferol has measurable systemic bioactivity and is dermally absorbable, exposure for babies (0–3 yr) is higher due to immature barrier — exposure score increased by +1. No infant-specific toxicity studies were located. (See animal/mechanistic studies and absorption data).
- VeriMom kaempferol nasıl puanlıyor?
- VeriMom kaempferol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
- Hamilelikte kaempferol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.